Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
Looking at the treatment of porphyria cutanea tarda in a person living with HIV.
View PublicationLooking at the treatment of porphyria cutanea tarda in a person living with HIV.
View PublicationExamining the global prevalence of chronic pain in women with HIV
View PublicationAssessing the effects of oral cannabinoids on HIV.
View PublicationLooking at bone mineral density in women living with HIV.
View PublicationExamining the risk of hospitalization within 14 days of COVID-19 diagnosis among people living with HIV (PLWH) and HIV-negative individuals who had laboratory-confirmed SARS-CoV-2 infection.
View PublicationConsidering interventions with the greatest potential for improving local STI testing services for GBM communities in Toronto, Ontario, Canada.
View PublicationConsidering how normative ideologies played out in COVID-19 directives and what impacts these orders had on the lives of gay, bisexual and queer men.
View PublicationConsidering whether elevated FGF23 predicts all-cause mortality in patients with HIV/HCV coinfection.
View PublicationConsidering barriers to use of PrEP and strategies that may facilitate its uptake.
View PublicationConsidering whether COVID-19 measures such as social distancing and isolation led to increases in loneliness and whether these measures may also have led to elevated sexual risk-taking among some GBM.
View Publication